Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:43:02.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2; no substantive changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:29:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the history display.
    Difference
    0.1%
    Check dated 2026-02-05T22:52:36.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 was added to the history, and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-15T04:31:56.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure footer link, which are administrative site updates and do not affect trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T14:00:33.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous v3.2.0. This appears to be a system/version update and does not modify study data or user-facing functionality.
    Difference
    0.1%
    Check dated 2025-11-25T14:43:44.000Z thumbnail image

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.